Atsuo Takashima

14PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 08, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancer.

|Jan 21, 2026
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603.

Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa

|Jan 15, 2026
Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan.

Nozomu Ogura, Hidekazu Hirano, Kouya Shiraishi

|Oct 24, 2024
Comprehensive Genomic Assessment of Advanced-Stage GI Stromal Tumors Using the Japanese National Center for Cancer Genomics and Advanced Therapeutics Database.

Hiroyuki Fujii, Hidekazu Hirano, Kouya Shiraishi

|Aug 30, 2024
Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study group.

Atsuo Takashima, Megumi Ishiguro, Keita Sasaki

|Aug 26, 2024
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018).

Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa

Pageof 3

Frequent Collaborators

3 joint publications

Kouya Shiraishi

3 joint publications

Ken Kato

3 joint publications

Toshiki Masuishi

2 joint publications

Sakura Iizumi